lenalidomide - Globe Thesis

Keyword [lenalidomide] Result: 1 - 20 \| Page: 1 of 3
1.	Lenalidomide In The Treatment Of Mantle Cell Lymphoma And Its Action Mechanism
2.	Effects Of Lenalidomide Alone Or Combination With Bortezomib On Proliferation And Apoptosis Of Mantle Cell Lymphoma Cells In Vivo And Vitro
3.	Association Of Cereblon Gene Expression With Lenalidomide Efficacy In Treating POEMS Syndrome
4.	Studies On The Mechanism Of Lenalidomide On The Growth Of Human Hepatoma Cell Line SMMC-7721Cells In Vitro And The Comparison Of Curative Effect With Thalidomide
5.	Observation Of Lenalidomide Plus Dexamethasone In Treatment Of Relapse/Refractory Multiple Myeloma
6.	Lenalidomide Affect The Expression Levels Of Cereblon For Multiple Myeloma Cell Line RPMI8226
7.	Amine Mechanism Of Tumor Associated Macrophages Interact With Cells Lymphoma And Lenalidomide
8.	Lenalidomide Role Of Tumor-associated Macrophage Cells And Its Effect On The Growth Of Lymphoma
9.	Maintenance Therapy With Lenalidomide Or Bortezomib In Patients With Multiple Myeloma:Meta-Analysis Of Randomized Controlled Trials
10.	The Mechanistic Study Of Thalidomide And Its Structure Analogs In Regulating CRBN And Substrates Of The Cullin 4 RING-CRBN E3 Ligase
11.	The Synergism Between Aspirin And Lenalidomide In Multiple Myeloma Cells And The Underlying Molecular Mechanisms
12.	The Clinical Study Of Lenalidomide In Combination With Chemotherapy In The Treatment Of Leukemia
13.	Design And Synthesis Of Lenalidomide Derivatives As Tumor Of Angiogenesis Inhibitor
14.	Studies On The Anti-Tumor Activity And Mechanisms Of The Combination Of Lenalidomide And Clarithromycin Against Multiple Myeloma
15.	Efficacy And Adverse Events Of Lenalidomide For Myelodysplastic Syndromes:A Systematic Review
16.	Activation Of C-Abl Kinase Potentiates The Anti-myeloma Drug Lenalidomide By Promoting DDA1 Recruitment To The CRL4 Ubiquitin Ligase
17.	The Significance Of PD-L1 Molecule In The Diagnosis And Treatment Of Non-Hodgkin's Lymphoma
18.	Part I Analysis Of Clinical Features And Prognostic Factors Of Chronic Lymphocytic Leukemia Part II The PD-1/PD-L1 Pathway Inhibitor Reverses The Immunosuppressive State Of Chronic Lymphocytic Leukemia
19.	Antithrombotic Prophylaxis For Multiple Myeloma Patients Receiving Immunmodulator: A Systematic Review
20.	Advances In Lenalidomide Therapy For Hematological System Diseases
<<First <Prev Next> Last>> Jump to